End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.24 USD | -1.59% | -8.15% | -49.59% |
04-30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
04-30 | Top Premarket Gainers | MT |
Valuation
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 173.5 | 144.7 | 46.58 | - |
Enterprise Value (EV) 1 | 173.5 | 144.7 | 46.58 | 46.58 |
P/E ratio | -111 x | -2.45 x | -4.96 x | -5.17 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | 160 x | 12.1 x | 7.58 x |
EV / Revenue | - | 160 x | 12.1 x | 7.58 x |
EV / EBITDA | - | -22,159,616 x | - | - |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 17,370 | 39,332 | 37,564 | - |
Reference price 2 | 9.990 | 3.680 | 1.240 | 1.240 |
Announcement Date | 05/12/22 | 30/10/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | 0.905 | 3.845 | 6.146 |
EBITDA | - | -6.532 | - | - |
EBIT 1 | - | -6.654 | -10.22 | -11.02 |
Operating Margin | - | -735.19% | -265.9% | -179.27% |
Earnings before Tax (EBT) 1 | - | -52.02 | -9.989 | -11.02 |
Net income 1 | -4.527 | -51.79 | -9.711 | -9.696 |
Net margin | - | -5,722.21% | -252.56% | -157.76% |
EPS 2 | -0.0900 | -1.500 | -0.2500 | -0.2400 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 05/12/22 | 30/10/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2023 Q4 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|
Net sales 1 | 0.905 | 0.2521 | 0.65 | 0.992 |
EBITDA | -0.4276 | - | - | - |
EBIT 1 | -0.5484 | -1.793 | -3.045 | -3.118 |
Operating Margin | -60.59% | -711.19% | -468.46% | -314.31% |
Earnings before Tax (EBT) 1 | -2.983 | -2.019 | -3.045 | -3.118 |
Net income 1 | -2.748 | -1.783 | -2.68 | -2.744 |
Net margin | -303.63% | -707.42% | -412.31% | -276.61% |
EPS 2 | -0.0300 | -0.0500 | -0.0700 | -0.0700 |
Dividend per Share | - | - | - | - |
Announcement Date | 30/10/23 | 13/03/24 | - | - |
Balance Sheet Analysis
Fiscal Period: June | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt | - | - | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex 1 | - | - | 0.23 | 0.46 |
Capex / Sales | - | - | 6.01% | 7.5% |
Announcement Date | 05/12/22 | 30/10/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.59% | 46.58M | |
+15.06% | 3.4B | |
-95.58% | 1.61B | |
-2.28% | 1.58B | |
-0.24% | 1.27B | |
-7.60% | 1.24B | |
-12.02% | 1.21B | |
-.--% | 1.23B | |
0.00% | 1.2B | |
-7.89% | 1.16B |
- Stock Market
- Equities
- MLEC Stock
- Financials Moolec Science SA